Bobby, Bradley Terrence (CPSO#: 78358)

Current Status: Active Member as of 25 Jul 2002

CPSO Registration Class: Restricted as of 11 Sep 2017

Indicates a concern or additional information

Summary

Former Name: No Former Name

Gender: Male

Languages Spoken: English

Education:The University of Manitoba, 1998

Practice Information

Primary Location of Practice
Family Medical Centre
387 Cedar Street
Simcoe ON  N3Y 2J2
Phone: (519) 426-4821
Fax: (519) 426-6649
Electoral District: 04
View Professional Corporation Information

Professional Corporation Information

Corporation Name: Bradley Bobby Medicine Professional Corporation

Certificate of Authorization Status: Issued Date:  Jan 04 2016

Shareholders:
Dr. B. Bobby ( CPSO# 78358 )

Business Address:
Family Medical Centre
387 Cedar Street
Simcoe ON  N3Y 2J2
Phone Number: (519) 426-4821

Hospital Privileges

Hospital Location
Norfolk General Hospital Simcoe

Registration History

Action Issue Date
First certificate of registration issued: Independent Practice Certificate Effective: 25 Jul 2002
Transfer of class of certificate to: Restricted certificate Effective: 11 Sep 2017
Terms and conditions imposed on certificate by member Effective: 11 Sep 2017

Practice Restrictions

Imposed By Effective Date Expiry Date Status  
member Effective: 11 Sep 2017 Active View Details [+]
            As from September 11, 2017, the following terms, conditions and limitations are
            imposed on the certificate of registration held by Dr. Bradley Terrence Bobby,
            in accordance with an undertaking and consent Dr. Bobby has given to the
            College of   Physicians and Surgeons of Ontario:

                               UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT 
                                            ("Undertaking")

                                                  of

                                      DR. BRADLEY TERRENCE BOBBY
                                             ("Dr. Bobby")

                                                  to 

                             COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
                                            (the "College")


            A.    PREAMBLE

            (1)   In this Undertaking:

                  "Code" means the Health Professions Procedural Code, which is Schedule 2
                  to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as
                  amended; 
                  
                  "ICR Committee" means the Inquiries, Complaints and Reports Committee of
                  the College.
                  
                  "Narcotic Drugs" means from the Narcotic Control Regulations made under
                  the Controlled Drugs and Substances Act, S.C., 1996, c. 19, as amended.
                  
                  "Narcotic Preparations" means from the Narcotic Control Regulations made
                  under the Controlled Drugs and Substances Act, S.C., 1996, c. 19, as
                  amended.
                  
                  "Controlled Drugs" means from Part G of the Food and Drug Regulations
                  under the Food and Drugs Act, S.C., 1985, c. F-27, as amended.
                  
                  "Benzodiazepines and Other Targeted Substances" means from the
                  Benzodiazepines and Other Targeted Substances Regulations made under the
                  Controlled Drugs and Substances Act., S.C., 1996, c. 19, as amended 
                        (A summary of the above-named drugs [from Appendix I to the
                        Compendium of Pharmaceuticals and Specialties] is attached hereto
                        as Schedule "A"; and the current regulatory lists are attached
                        hereto as Schedule "B")
                  
                  "All other Monitored Drugs" means as defined under the Narcotics Safety
                  and Awareness Act, 2010, S.O. 2010, c. 22, as amended, as noted in
                  Schedule "C".                                                
                  
                  "NMS" means the Drug Program Services Branch, the Narcotics Monitoring
                  System implemented under the Narcotics Safety and Awareness Act, 2010,
                  S.O. 2010, c. 22, as amended;
                  
                  "OHIP" means the Ontario Health Insurance Plan;
                  
                  "Public Register" means the College's register that is available to the
                  public.
                  
            (2)   I, Dr. Bobby, certificate of registration number 78358, am a member of
                  the College.  

            (3)   I, Dr. Bobby, acknowledge that the College received information from the
                  NMS and initiated an investigation bearing File Number 7215553 (the
                  "Investigation") into whether I failed to maintain the standard of
                  practice of the profession and/or am incompetent in my prescribing of
                  controlled substances, including narcotics.

            (4)   I, Dr. Bobby, acknowledge that, if an original copy of this Undertaking
                  as signed by me is accepted by the Inquiries, Complaints and Reports
                  Committee, the College will also deliver a caution in person.


            B.    UNDERTAKING

            (5)   I, Dr. Bobby, undertake to abide by the provisions of this Undertaking
                  effective upon the date this Undertaking is approved by the ICR Committee
                  ("Effective Date").

            (6)   I, Dr. Bobby, shall keep a log of all prescriptions for Narcotic Drugs,
                  Narcotic Preparations, Controlled Drugs, Benzodiazepines and Other
                  Targeted Substances and All other Monitored Drugs, in the form attached
                  as set out in Schedule "D", which will include at least the following
                  information (the "Prescribing Log"):  

                  (i)   the date of the appointment;
                  (ii)  the name of the patient and chart/file number;
                  (iii) the name of the medication prescribed, dose, direction, number of
                        tablets to be dispensed and frequency;
                  (iv)  the clinical indication;
                  (v)   whether the prescription is for a new medication and/or different
                        dose or frequency than currently prescribed to the patient (Y/N); 
                  (vi)  Dr. Bobby's signature;
                  (vii) the date of the Clinical Supervisor's review (if applicable, as set
                        out                                                          
                        below); and
                  (viii)the Clinical Supervisor's signature (if applicable, as set out
                        below).
                  
            (7)   I, Dr. Bobby, undertake to keep a copy of all prescriptions I write for
                  Narcotic Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines
                  and Other Targeted Substances and All other Monitored Drugs, in the
                  corresponding patient chart.

            (8)   Clinical Supervision

                  (a)   I, Dr. Bobby, undertake to practise under the guidance of a
                        clinical supervisor(s) acceptable to the College (the "Clinical
                        Supervisor(s)"), for a minimum of twelve (12) months on the terms
                        set out below (the "Clinical Supervision"). 
                  
                  (b)   I, Dr. Bobby, acknowledge and undertake that each phase of Clinical
                        Supervision set out below will only be reduced upon recommendation
                        of the Clinical Supervisor(s) and approval by the College.
                  
                  Phase 1 of Clinical Supervision ("Phase 1")
                  
                  (c)   I, Dr. Bobby, undertake to engage in Phase 1 of Clinical
                        Supervision for a minimum of four (4) weeks on the terms set out
                        below.
                  
                  (d)   During Phase 1, I, Dr. Bobby, undertake to review every patient
                        with my Clinical Supervisor(s) prior to issuing a continuing
                        prescription for any Narcotic Drugs, Narcotic Preparations,
                        Controlled Drugs, Benzodiazepines and Other Targeted Substances and
                        All other Monitored Drugs to ensure that assessment, clinical
                        examination, risk assessment for addiction and on-going management
                        and follow up is appropriate.
                  
                  (e)   During Phase 1, I, Dr. Bobby, undertake not to initiate any new
                        prescription for Narcotic Drugs, Narcotic Preparations, Controlled
                        Drugs, Benzodiazepines and Other Targeted Substances and All other
                        Monitored Drugs to any patient who is not currently prescribed the
                        medication in question by me, unless recommended by my Clinical
                        Supervisor(s).
                  
                  (f)   During Phase 1, I, Dr. Bobby, undertake to ensure that my Clinical
                        Supervisor(s) directly observes at least three (3) patient
                        encounters per week where I issue a prescription for Narcotic
                        Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and
                        Other Targeted Substances and All other Monitored Drugs.
                  
                  (g)   During Phase 1, I, Dr. Bobby, undertake to ensure that my Clinical
                        Supervisor(s) confirms his or her review of my patient care with me
                        as described in (10)(d) and (f) above by signing the Prescribing
                        Log and the patient chart in question prior to my issuing any
                        prescription for Narcotic Drugs, Narcotic Preparations, Controlled
                        Drugs, Benzodiazepines and Other Targeted Substances and All other
                        Monitored Drugs.
                  
                  (h)   I, Dr. Bobby, acknowledge that during Phase 1, the Clinical
                        Supervisor(s) will provide a report to the College at least once
                        every two weeks.
                  
                  
                  
                  (i)   I, Dr. Bobby, acknowledge that after a minimum of four (4) weeks of
                        Phase 1, if the Clinical Supervisor(s) is satisfied that I have the
                        necessary knowledge, skills and judgment to practice in a less
                        highly supervised environment, the Clinical Supervisor(s) may
                        recommend to the College that supervision be reduced. 
                  
                  
                  Phase 2 of Clinical Supervision ("Phase 2")
                  
                  (j)   I, Dr. Bobby, undertake to engage in Phase 2 of Clinical
                        Supervision for a minimum of eight (8) weeks on the terms set out
                        below.
                  
                  (k)   During Phase 2, I, Dr. Bobby, undertake to meet with my Clinical
                        Supervisor(s) at least once every week to discuss the Clinical
                        Supervisor(s)'s review of:
                        i.    20 charts for patients to whom I have prescribed Narcotic
                              Drugs, Narcotic Preparations, Controlled Drugs,
                              Benzodiazepines and Other Targeted Substances and All other
                              Monitored Drugs since the Clinical Supervisor(s)'s prior
                              review, or if there are not 20 patients listed in the
                              Prescribing Log meeting the description set out in (i) since
                              the Clinical Supervisor(s)'s prior review, then the charts of
                              all patients listed in the Prescribing Log meeting the
                              description set out in (i) since the Clinical Supervisor's
                              prior review; and
                        ii.   At least 10 charts of patients to whom I have initiated a new
                              prescription for:
                              1.    Narcotic Drugs, or
                              2.    Narcotic Preparations; or
                              3.    Controlled Drugs, Benzodiazepines and Other Targeted
                                    Substances and All other Monitored Drugs where the
                                    patient is also prescribed a Narcotic Drug and/or
                                    Narcotic Preparation,
                              or if there are not 10 patients listed in the Prescribing Log
                              since the Clinical Supervisor(s)'s prior review meeting the
                              description set out in (ii), then the charts of all patients
                              listed in the Prescribing Log meeting the description set out
                              in (ii) since the Clinical Supervisor's prior review.
                  
                  (l)   I, Dr. Bobby, acknowledge that during Phase 2, the Clinical
                        Supervisor(s) must sign and date the Prescribing Log to confirm the
                        charts that the Clinical Supervisor(s) have reviewed and discussed
                        with me.
                  
                  (m)   I, Dr. Bobby, acknowledge that during Phase 2, the Clinical
                        Supervisor(s) will provide a report to the College at least once
                        every two weeks.
                  
                  (n)   I, Dr. Bobby, acknowledge that after a minimum of eight (8) weeks
                        of Phase 2, if the Clinical Supervisor(s) is satisfied that I have
                        the necessary knowledge, skills and judgment to practice in a less
                        highly supervised environment, the Clinical Supervisor(s) may
                        recommend to the College that supervision be reduced. 
                  
                  Phase 3 of Clinical Supervision ("Phase 3")
                  
                  (o)   Upon the recommendation of the Clinical Supervisor(s) and approval
                        by the College, I, Dr. Bobby, undertake to engage in Phase 3 of
                        Clinical Supervision for a minimum of nine (9) months on the terms
                        set out below.
                  
                  (p)   During Phase 3, I, Dr. Bobby, undertake to meet with my Clinical
                        Supervisor(s) at least once every month to discuss the Clinical
                        Supervisor(s)'s review of:
                        i.    15 charts for patients to whom I have prescribed Narcotic
                              Drugs, Narcotic Preparations, Controlled Drugs,
                              Benzodiazepines and Other Targeted Substances and All other
                              Monitored Drugs since the Clinical Supervisor(s)'s prior
                              review, or if there are not 15 patients listed in the
                              Prescribing Log meeting the description set out in (i) since
                              the Clinical Supervisor(s)'s prior review, then the charts of
                              all patients listed in the Prescribing Log meeting the
                              description set out in (i) since the Clinical Supervisor's
                              prior review; and
                        ii.   At least 10 charts of patients to whom I have initiated a new
                              prescription for:
                              1.    Narcotic Drugs, or
                              2.    Narcotic Preparations; or
                              3.    Controlled Drugs, Benzodiazepines and Other Targeted
                                    Substances and All other Monitored Drugs where the
                                    patient is also prescribed a Narcotic Drug and/or
                                    Narcotic Preparation,
                              or if there are not 10 patients listed in the Prescribing Log
                              since the Clinical Supervisor(s)'s prior review meeting the
                              description set out in (ii), then the charts of all patients
                              listed in the Prescribing Log meeting the description set out
                              in (ii) since the Clinical Supervisor's prior review.
                  
                  (q)   I, Dr. Bobby, acknowledge that during Phase 3, the Clinical
                        Supervisor(s) must sign and date the Prescribing Log to confirm the
                        charts that the Clinical Supervisor(s) have reviewed and discussed
                        with me.
                  
                  (r)   I, Dr. Bobby, acknowledge that during Phase 3, the Clinical
                        Supervisor(s) will provide a report to the College at least once
                        every month.
                  
                  (s)   I, Dr. Bobby, acknowledge that after a minimum of nine (9) months
                        of Phase 2, if the Clinical Supervisor(s) is satisfied that I have
                        the necessary knowledge, skills and judgment to practice without
                        supervision, the Clinical Supervisor(s) may recommend to the
                        College that the Clinical Supervision cease.
                  
                  (t)   I, Dr. Bobby, acknowledge and undertake that the Clinical
                        Supervision will only cease upon recommendation of the Clinical
                        Supervisor(s) and approval by the College.
                  
                  
                  
                  (u)   I, Dr. Bobby, acknowledge that I have reviewed the Clinical
                        Supervisor(s)'s undertaking, attached hereto as Schedule "E", and
                        understand what is required of the Clinical Supervisor(s).  In
                        addition to what is set out above, the Clinical Supervisor(s) will,
                        at a minimum: 
                  
                        (i)   Facilitate the education program set out in the
                              Individualized Education Plan ("IEP") attached as Schedule
                              "F";
                  
                        (ii)  Discuss any concerns with me arising from chart reviews and
                              observations;
                  
                        (iii) Make recommendations to me for practice improvements and
                              ongoing professional development and inquire into my
                              compliance with the recommendations; and
                  
                        (iv)  Perform any other duties, such as reviewing other documents
                              or conducting interviews with staff or colleagues, that the
                              Clinical Supervisor(s) deem necessary to my Clinical
                              Supervision.
                  
                  (v)   I, Dr. Bobby, undertake that all meetings with my Clinical
                        Supervisor(s) will take place at my Practice Location, or another
                        location approved by the College;
                  
                  (w)   I, Dr. Bobby, acknowledge that all charts reviewed shall be
                        independently selected by the Clinical Supervisor(s) based on the
                        educational needs identified in the IEP set out at Schedule "F" to
                        my Undertaking, as well as the areas of concern identified in the
                        report of the medical inspector dated May 25 2017, and concerns
                        that may arise during the period of Clinical Supervision.
                  
                  (x)   I, Dr. Bobby, undertake to cooperate fully with the Clinical
                        Supervision of my practice, conducted under the terms of this
                        Undertaking and Schedule "E" attached, and to abide by the
                        recommendations of my Clinical Supervisor(s), including but not
                        limited to, any recommended practice improvements and ongoing
                        professional development.
                  
                  (y)   I, Dr. Bobby, undertake to ensure that Schedule "E" to this
                        Undertaking, is signed and delivered to the College within fourteen
                        (14) days of the Effective Date.
                  
                  (z)   I, Dr. Bobby, undertake that if a person who has given an
                        undertaking in Schedule "E" to this Undertaking is unable or
                        unwilling to continue to fulfill its provisions, I shall, within
                        fourteen (14) days of receiving notice of same, obtain an executed
                        undertaking in the same form from a similarly qualified person who
                        is acceptable to the College and ensure that it is delivered to the
                        College within that time.
                  
                  
                  
                  (aa)  I, Dr. Bobby, agree that if I am unable to obtain a Clinical
                        Supervisor on the terms set out in sections (7)(y) and/or (z)
                        above, I will cease prescribing Narcotic Drugs, Narcotic
                        Preparations, Controlled Drugs, Benzodiazepines and Other Targeted
                        Substances and All other Monitored Drugs until such time as I have
                        obtained a Clinical Supervisor acceptable to the College.  
                  
                  (bb)  I, Dr. Bobby, agree that if I am required to cease prescribing
                        Narcotic Drugs, Narcotic Preparations, Controlled Drugs,
                        Benzodiazepines and Other Targeted Substances and All other
                        Monitored Drugs as a result of section (7)(aa) above this will
                        constitute a term, condition or limitation on my certificate of
                        registration and that term, condition or limitation will be
                        included on the Public Register.
                  
            (9)   Professional Education  

                  (a)   I, Dr. Bobby, undertake to participate in and successfully complete
                        all elements of the detailed IEP, attached hereto as Schedule "F",
                        including but not limited to, the following elements of
                        professional education (the "Professional Education"):
                  
                        (i)   University of Toronto Faculty of Medicine program in Safe
                              Opioid Prescribing (all three webinars and in-person
                              workshop): www.cepd.utoronto.ca/opioidprescribing;
                        (ii)  Review and discuss with my Clinical Supervisor(s) the
                              following resources:
                          1.    CPSO Policy "Prescribing
                                Drugs":http://www.cpso.on.ca/Policies-Publications/Policy/Prescribing-Drugs;
               
                          2.    2017 Canadian Guideline for Opioids for Chronic
                                Non-Cancer Pain:
                                http://nationalpaincentre.mcmaster.ca/guidelines.html;
               
                          3.     CMPA advice regarding preventing the misuse of opioids
                                https://www.cmpa-acpm.ca/en/advice-publications/browse-articles/2015/preventing-the-misuse-of-opioids
               
                          4.    Effective Practice Management of Chronic Non-Cancer Pain
                                Tool https://thewellhealth.ca/cncp
               
                          5.    College Medical Record policy
                                http://www.cpso.on.ca/Policies-Publications/Policy/Medical-Records
                    (iii) any additional professional education recommended by my
                          Clinical Supervisor(s).
               
               (b)  I, Dr. Bobby, undertake to provide proof to the College of my
                    successful completion of each element of the Professional Education
                    specified above, including proof of registration, attendance and
                    participant assessment reports where available, within one (1) month
                    of completion of each element. I acknowledge that the College will
                    determine, in its sole discretion, whether I have successfully
                    completed each element of the Professional Education.
               
               (c)  I, Dr. Bobby, acknowledge that a report or reports may be provided
                    to the College regarding my progress and compliance with the
                    Professional Education.
               
         (10)  Reassessment of Practice

               (a)  I, Dr. Bobby, undertake that, approximately six (6) months  after
                    the Clinical Supervision set out under section 7 of the Undertaking
                    has ceased, I will submit to a reassessment of my practice by an
                    assessor or assessors selected by the College (the "Reassessment").

               (b)  I, Dr. Bobby, acknowledge and agree that the Reassessment may
                    include a chart review, direct observation of my care, an interview
                    of me, interviews with colleagues and co-workers, feedback from
                    patients and any other tools deemed necessary by the College.
               
               (c)  I, Dr. Bobby, undertake to co-operate fully with the Reassessment,
                    conducted under the terms of this Undertaking 
               
               (d)  I, Dr. Bobby, acknowledge and agree that my Clinical Supervisor(s)
                    may receive and review the findings of the Assessor(s), and may
                    discuss with the Assessor(s) any issues or concerns arising from the
                    Reassessment.  
               
               (e)  I, Dr. Bobby, acknowledge that the results of the Reassessment will
                    be provided to me and reported to the College and that the
                    Reassessment may form the basis of further action by the College.
               
         (11)  Monitoring 

               (a)  I, Dr. Bobby, undertake to inform the College of each and every
                    location that I practise or have privileges, including, but not
                    limited to, hospital(s), clinic(s) and office(s), in any
                    jurisdiction (collectively my "Practice Location(s)"), within ten
                    (10) business days of executing this Undertaking.  Going forward, I
                    further undertake to inform the College of any and all new Practice
                    Locations within ten (10) business days of commencing practice at
                    that location.
               
               (b)  I, Dr. Bobby, undertake and agree that I will submit to, and not
                    interfere with, unannounced inspections of my Practice Location(s)
                    and patient records by a College representative for the purposes of
                    monitoring my compliance with the provisions of this Undertaking.
               
               
               (c)  I, Dr. Bobby, give my irrevocable consent to the College to make
                    appropriate enquiries of the Ontario Health Insurance Plan ("OHIP"),
                    the Drug Program Services Branch, the Narcotics Monitoring System
                    ("NMS") implemented under the Narcotics Safety and Awareness Act,
                    2010 and/or any person or institution who may have relevant
                    information, in order for the College to monitor my compliance with
                    the provisions of this Undertaking. 
               
               (d)  I, Dr. Bobby, acknowledge that I have executed the OHIP and NMS
                    consent form(s), attached hereto as Schedule "G" and Schedule "H",
                    respectively. 
               
         C.    ACKNOWLEDGEMENT

         (12)  I, Dr. Bobby, acknowledge that all schedules attached to or referred to
               in this Undertaking form part of this Undertaking.

         (13)  I, Dr. Bobby, acknowledge that I shall be solely responsible for payment
               of all fees, costs, charges, expenses, etc. arising from the
               implementation of any of the provisions of this Undertaking. 

         (14)  I, Dr. Bobby, acknowledge and confirm that I have read and understand the
               provisions of this Undertaking and that I have obtained independent legal
               counsel in reviewing and executing this Undertaking, or have waived my
               right to do so.

         (15)  I, Dr. Bobby, acknowledge that the College will provide this Undertaking
               to any Chief of Staff, or a colleague with similar responsibilities, at
               any Practice Location ("Chief(s) of Staff").

         (16)  I, Dr. Bobby, acknowledge that a breach by me of any provision of this
               Undertaking may constitute an act of professional misconduct and/or
               incompetence, and may result in a referral of specified allegations to
               the Discipline Committee of the College.

         (17)  I, Dr. Bobby, acknowledge that this entire Undertaking constitutes terms,
               conditions, and limitations on my certificate of registration for the
               purposes of section 23 of the Code. 

         (18)  Public Register

               (a)  I, Dr. Bobby, acknowledge that, during the time period that this
                    Undertaking remains in effect, this Undertaking shall be posted on
                    the Public Register.
               
               
               (b)  I, Dr. Bobby, acknowledge that, in addition to this Undertaking
                    being posted in accordance with the section above, the following
                    summary shall be posted on the Public Register during the time
                    period that this Undertaking remains in effect:
               
                    The College received information from the Narcotics Monitoring
                    System about Dr. Bobby's prescribing of controlled substances,
                    including narcotics.
               
                    Based on the information received, the College conducted an
                    investigation into whether Dr. Bobby failed to maintain the standard
                    of practice of the profession and/or was incompetent in his
                    prescribing of controlled substances, including narcotics.  As a
                    result of the investigation:
               
                          *     Dr. Bobby's prescribing of narcotic drugs, narcotic
                                preparations, controlled drugs, benzodiazepines and
                                other targeted substances, and other monitored drugs
                                will be supervised by a Clinical Supervisor acceptable
                                to the College for a minimum of twelve (12) months. 
               
                          *     Dr. Bobby will engage in professional education in the
                                prescribing of controlled substances, including
                                narcotics.
               
                          *     Following the professional education and period of
                                supervision, Dr. Bobby's prescribing of controlled
                                substances, including narcotics, will be re-assessed by
                                an assessor selected by the College.
               
         D.    CONSENT

         (19)  I, Dr. Bobby, give my irrevocable consent to the College to provide the
               following information to any person who requires this information for the
               purposes of facilitating my completion of the Professional Education and
               to all Clinical Supervisors, and/or Assessors:

               (a)  any information the College has that led to the circumstances of my
                    entering into this Undertaking;
               
               (b)  any information arising from any investigation into, or assessment
                    of, my practice; and 
               
               (c)  any information arising from the monitoring of my compliance with
                    this Undertaking.
               
         (20)  I, Dr. Bobby, give my irrevocable consent to the College to provide all
               Chief(s) of Staff with any information the College has that led to the
               circumstances of my entering into this Undertaking and/or any information
               arising from the monitoring of my compliance with this Undertaking.

         (21)  I, Dr. Bobby, give my irrevocable consent to any person who facilitates
               my completion of the Professional Education, and to all Clinical
               Supervisors, Chiefs of Staff and Assessors, to disclose to the College,
               and to one another, any information:

               (a)  relevant to this Undertaking;
               
               (b)  relevant to the provisions of the Clinical Supervisor's undertaking
                    set out at Schedule "E";
               
               (c)  relevant to the Reassessment;
               
               (d)  relevant for the purposes of monitoring my compliance with this
                    Undertaking; and/or  
               
               (e)  which comes to his or her attention in the course of providing the
                    Professional Education and which he or she reasonably believes
                    indicates a potential risk of harm to my patients.
               

Concerns

Source: ICR Committee
Active Date: September 11, 2017
Expiry Date:
Summary:
Caution-in-Person:

A summary of a decision of the Inquiries, Complaints and Reports Committee in which the disposition includes a "caution-in-person" is required by the College by-laws to be posted on the register, along with a note if the decision has been appealed. A “caution-in-person” disposition requires the physician to attend at the College and be verbally cautioned by a panel of the Committee. The summary will be removed from the register if the decision is overturned on appeal or review. Note that this requirement only applies to decisions arising out of a complaint dated on or after January 1, 2015 or if there was no complaint, the first appointment of investigators dated on or after January 1, 2015.
Download Full Document (PDF)


Source: Member
Active Date: August 9, 2017
Expiry Date:
Summary:
Summary of the Undertaking given by Dr. Bradley Terrence Bobby to the College of Physicians and Surgeons of Ontario, effective September 11, 2017:

The College received information from the Narcotics Monitoring System about Dr. Bobby’s prescribing of controlled substances, including narcotics.

Based on the information received, the College conducted an investigation into whether Dr. Bobby failed to maintain the standard of practice of the profession and/or was incompetent in his prescribing of controlled substances, including narcotics. As a result of the investigation:

Dr. Bobby’s prescribing of narcotic drugs, narcotic preparations, controlled drugs, benzodiazepines and other targeted substances, and other monitored drugs will be supervised by a Clinical Supervisor acceptable to the College for a minimum of twelve (12) months.

Dr. Bobby will engage in professional education in the prescribing of controlled substances, including narcotics.

Following the professional education and period of supervision, Dr. Bobby’s prescribing of controlled substances, including narcotics, will be re-assessed by an assessor selected by the College.